Article Information
History
- November 14, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zhaohui Du1,
- Tejaswi Iyyanki1,
- Samuel Lessard1,
- Michael Chao1,
- FinnGen,
- Christian Asbrand2,
- Dany Nassar3,
- Katherine Klinger4,
- Emanuele de Rinaldis1,
- Shameer Khader1 and
- Clément Chatelain1,*
- 1Precision Medicine & Computational Biology, Sanofi, Cambridge, MA, USA
- 2Type 1/17 Inflammation Cluster, Sanofi, Frankfurt, Germany
- 3Early Immunology & Inflammation Development Clinical Team, Sanofi, Chilly-Mazarin, France
- 4Genetics Research, Sanofi, Cambridge, MA, USA
- ↵*Corresponding author Name
Clément Chatelain Address
350 Water Street Cambridge, MA, USA 02141 E-mail
Clement.Chatelain{at}sanofi.com